Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from the Department of Human Services.

The medicines listed for prescribing by authorised nurse practitioners from 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 49 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from the Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • MWMidwife
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 10734Y NADROPARINnadroparin calcium 7600 anti-Xa international units/0.8 mL injection, 2 x 0.8 mL syringes 5 10 1
MPNP 10740G NADROPARINnadroparin calcium 7600 anti-Xa international units/0.8 mL injection, 2 x 0.8 mL syringes 10 20 3
MPNP 10687L NADROPARINnadroparin calcium 1900 anti-Xa international units/0.2 mL injection, 2 x 0.2 mL syringes 10 20 3
MPNP 10735B NADROPARINnadroparin calcium 1900 anti-Xa international units/0.2 mL injection, 2 x 0.2 mL syringes 10 20 0
MPNP 10685J NADROPARINnadroparin calcium 3800 anti-Xa international units/0.4 mL injection, 2 x 0.4 mL syringes 10 20 0
MPNP 10717C NADROPARINnadroparin calcium 3800 anti-Xa international units/0.4 mL injection, 2 x 0.4 mL syringes 10 20 3
MPNP 10686K NADROPARINnadroparin calcium 2850 anti-Xa international units/0.3 mL injection, 2 x 0.3 mL syringes 10 20 0
MPNP 10701F NADROPARINnadroparin calcium 2850 anti-Xa international units/0.3 mL injection, 2 x 0.3 mL syringes 10 20 3
MPNP 10707M NADROPARINnadroparin calcium 19 000 anti-Xa international units/mL injection, 2 x 1 mL syringes 5 10 1
MPNP 10716B NADROPARINnadroparin calcium 5700 anti-Xa international units/0.6 mL injection, 2 x 0.6 mL syringes 10 20 0
MPNP 10718D NADROPARINnadroparin calcium 5700 anti-Xa international units/0.6 mL injection, 2 x 0.6 mL syringes 10 20 3
MPNP 10725L NADROPARINnadroparin calcium 15 200 anti-Xa international units/0.8 mL injection, 2 x 0.8 mL syringes 5 10 1
MPNP 10706L NADROPARINnadroparin calcium 11 400 anti-Xa international units/0.6 mL injection, 2 x 0.6 mL syringes 5 10 1
MPNP 10702G NADROPARINnadroparin calcium 9500 anti-Xa international units/mL injection, 2 x 1 mL syringes 5 10 1
MPNP 10733X NADROPARINnadroparin calcium 9500 anti-Xa international units/mL injection, 2 x 1 mL syringes 10 20 3
MPNP 11233F NALOXONEnaloxone hydrochloride 400 microgram/mL injection, 10 x 1 mL ampoules 1 10 0
MPNP 11078C NALOXONEnaloxone hydrochloride 1 mg/mL injection, 2 mL syringe 1 1 0
MPNP 10783M NALOXONEnaloxone hydrochloride 400 microgram/mL injection, 5 x 1 mL ampoules 1 5 0
MPNP 10786Q NALOXONEnaloxone hydrochloride 400 microgram/mL injection, 5 x 1 mL ampoules 2 10 0
MPNP 8370M NALTREXONEnaltrexone hydrochloride 50 mg tablet, 30 1 30 1
MPNP 1615B NAPROXENnaproxen 1 g modified release tablet, 28 1 28 3
MPNP 5348L NAPROXENnaproxen 1 g modified release tablet, 28 1 28 3
MPNP 1658G NAPROXENnaproxen 125 mg/5 mL oral liquid, 474 mL 1 1 3
MPNP 5397C NAPROXENnaproxen 125 mg/5 mL oral liquid, 474 mL 1 1 3
MPNP 1674D NAPROXENnaproxen 250 mg tablet, 50 2 100 3
MPNP 5345H NAPROXENnaproxen 250 mg tablet, 50 2 100 3
MPNP 1659H NAPROXENnaproxen 500 mg tablet, 50 1 50 3
MPNP 5346J NAPROXENnaproxen 500 mg tablet, 50 1 50 3
MPNP 1795L NAPROXENnaproxen sodium 550 mg tablet, 50 1 50 3
MPNP 5353R NAPROXENnaproxen sodium 550 mg tablet, 50 1 50 3
MPNP 1614Y NAPROXENnaproxen 750 mg modified release tablet, 28 1 28 3
MPNP 5347K NAPROXENnaproxen 750 mg modified release tablet, 28 1 28 3
MPNP 8298R NARATRIPTANnaratriptan 2.5 mg tablet, 2 2 4 5
MPNP 9734H NARATRIPTANnaratriptan 2.5 mg tablet, 2 2 4 5
MPNP 9311C NEBIVOLOLnebivolol 5 mg tablet, 28 1 28 5
MPNP 9316H NEBIVOLOLnebivolol 1.25 mg tablet, 28 2 56 5
MPNP 9312D NEBIVOLOLnebivolol 10 mg tablet, 28 1 28 5
MPNP 8365G NEDOCROMILnedocromil sodium 2 mg/actuation pressurised inhalation, 112 actuations 1 1 5
MPNP 10731T NETUPITANT + PALONOSETRONnetupitant 300 mg + palonosetron 500 microgram capsule, 1 1 1 5
MPNP 8229D NICORANDILnicorandil 20 mg tablet, 60 1 1 5
MPNP 8228C NICORANDILnicorandil 10 mg tablet, 60 1 1 5
MPNP 5572G NICOTINEnicotine 14 mg/24 hours patch, 28 1 28 2
MPNP 3414Q NICOTINEnicotine 21 mg/24 hours patch, 28 1 28 2
MPNP 5465P NICOTINEnicotine 21 mg/24 hours patch, 28 1 28 2
MPNP 5571F NICOTINEnicotine 21 mg/24 hours patch, 28 1 28 2
MPNP 10076H NICOTINEnicotine 25 mg/16 hours patch, 28 1 28 2
MPNP 5573H NICOTINEnicotine 7 mg/24 hours patch, 28 1 28 2
MPNP 8610E NIFEDIPINEnifedipine 20 mg modified release tablet, 30 1 30 5
MPNP 1906H NIFEDIPINEnifedipine 30 mg modified release tablet, 30 1 30 5
MPNP 1695F NIFEDIPINEnifedipine 20 mg tablet, 60 1 60 5
MPNP 1907J NIFEDIPINEnifedipine 60 mg modified release tablet, 30 1 30 5
MPNP 1694E NIFEDIPINEnifedipine 10 mg tablet, 60 1 60 5
MPNP 8131Y NILUTAMIDEnilutamide 150 mg tablet, 30 1 30 5
MPNP 2723H NITRAZEPAMnitrazepam 5 mg tablet, 25 1 25 0
MPNP 2732T NITRAZEPAMnitrazepam 5 mg tablet, 25 2 50 5
MPNP 5359C NITRAZEPAMnitrazepam 5 mg tablet, 25 2 50 3
MPMWNP 1693D NITROFURANTOINnitrofurantoin 100 mg capsule, 30 1 30 1
MPMWNP 1692C NITROFURANTOINnitrofurantoin 50 mg capsule, 30 1 30 1
MPNP 1505F NIZATIDINEnizatidine 150 mg capsule, 60 1 60 5
MPNP 1504E NIZATIDINEnizatidine 300 mg capsule, 30 1 30 5
MPNP 2993M NORETHISTERONEnorethisterone 5 mg tablet, 30 1 30 2
MPNP 1967M NORETHISTERONEnorethisterone 350 microgram tablet, 4 x 28 1 4 2
MPNP 2775C NORETHISTERONE + ETHINYLESTRADIOLnorethisterone 1 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 1 4 2
MPNP 2774B NORETHISTERONE + ETHINYLESTRADIOLnorethisterone 500 microgram + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 1 4 2
MPNP 3179H NORETHISTERONE + MESTRANOLnorethisterone 1 mg + mestranol 50 microgram tablet [21] (&) inert substance tablet [7], 4 x 28 1 4 2
MPNP 8425K NORETHISTERONE ACETATE + ESTRADIOL (&) ESTRADIOLestradiol 50 microgram/24 hours patch [4] (&) estradiol 50 microgram/24 hours + norethisterone acetate 140 microgram/24 hours patch [4], 8 1 1 5
MPNP 8426L NORETHISTERONE ACETATE + ESTRADIOL (&) ESTRADIOLestradiol 50 microgram/24 hours patch [4] (&) estradiol 50 microgram/24 hours + norethisterone acetate 250 microgram/24 hours patch [4], 8 1 1 5
MPNP 3010K NORFLOXACINnorfloxacin 400 mg tablet, 14 1 14 1
MPNP 2523T NORTRIPTYLINEnortriptyline 25 mg tablet, 50 1 50 2
MPNP 2522R NORTRIPTYLINEnortriptyline 10 mg tablet, 50 1 50 2
MPNP 1698J NYSTATINnystatin 100 000 units/g cream, 15 g 2 2 3
MPNP 1699K NYSTATINnystatin 500 000 units capsule, 50 1 50 0
MPNP 1696G NYSTATINnystatin 500 000 units tablet, 50 1 50 0